Communiqués Navamedic ASA

Actions

NAVA

NO0010205966

Produits pharmaceutiques

Marché Fermé - Oslo Bors 16:45:00 14/08/2026			Varia. 5j.	Varia. 1 janv.
16,60 ^NOK	-7,52%		-1,48%	-30,25%

15/08	Transcript : Navamedic ASA, Q2 2026 Earnings Call, Aug 14, 2026
14/08	Navamedic ASA publie ses prévisions de résultats pour l'exercice 2026	CI

Communiqués

14/08	Navamedic ASA: Growth and double-digit adjusted EBITDA margin in Q2 and first half 2026	AQ
10/08	Navamedic ASA: Invitation to presentation of second quarter and first half year 2026 results	AQ
26/06	Navamedic ASA: Mandatory notification of trade	AQ
16/06	Navamedic ASA: Change in leadership	AQ
21/05	Navamedic launches Virono®- the first single-dose over-the-counter cold sore tablet	AQ
20/05	Major shareholder disclosure in Navamedic ASA	AQ
18/05	Navamedic ASA: Mandatory notification of trade	AQ
23/04	Navamedic ASA: Minutes of Annual General Meeting	AQ
23/04	Navamedic ASA: Steady performance and continued product launch in Q1 2026	AQ
20/04	Navamedic ASA: Invitation to presentation of first quarter 2026 results	AQ
15/04	Navamedic : Recommendation of the nomination committee 2026	PU
15/04	Navamedic ASA: Recommendation of the nomination committee for the Annual General Meeting on 23 April 2026	AQ
31/03	Navamedic ASA: Notice of Annual General Meeting	AQ
27/02	Navamedic ASA: Mandatory notification of trade	AQ
12/02	Navamedic ASA: Strong growth and important product launch in Q4 2025	AQ
09/02	Navamedic ASA: Invitation to presentation of fourth quarter 2025 results	AQ
13/01	Navamedic : Minutes EGM January 2026	PU
07/01	Navamedic ASA: Minutes of Extraordinary General Meeting	AQ
12/12	Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026	AQ
08/12	Navamedic ASA: Appointment of CFO	AQ
28/11	Navamedic ASA: Resignation of CFO	AQ
28/10/25	Navamedic ASA: Double digit growth in the 3rd quarter, 2025	AQ
28/10/25	Navamedic ASA: Double digit growth in the 3rd quarter, 2025	AQ
24/10/25	Navamedic ASA: Invitation to 2025 3rd quarter presentation	AQ
17/10/25	Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical	AQ